Evidence map›Paper›PMID 41601476›Full record

ReviewFrontiers in bioinformatics2025

Recent trends in machine learning and deep learning-based prediction of G-protein coupled receptor-ligand binding affinities.

Joshua Stephenson, Konda Reddy Karnati

Abstract readReview
In one paragraph

Review in Frontiers in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Joshua StephensonDepartment of Natural Sciences, Bowie State University, Bowie, MD, United States.
Konda Reddy KarnatiDepartment of Natural Sciences, Bowie State University, Bowie, MD, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurately predicting protein-ligand binding affinity is key in drug discovery. Machine Learning and Deep Learning methods used in the drug discovery process have advanced the prediction of drug-target binding affinities, particularly for G protein-coupled receptors (GPCRs), a pharmacologically significant yet structurally heterogeneous protein family. In this review, binding affinity prediction models are examined and organized according to sequence-based one-dimensional, graph-based two-dimensional, and structure-based three-dimensional frameworks. Sequence-based models utilize convolutional neural networks for high-throughput screening. Recently published models incorporated attention mechanisms and self-supervised learning, enhancing interpretability and reducing dependence on annotated datasets. Graph-based models employ graph neural networks and molecular contact maps to capture topological features, enabling substructure-sensitive predictions. Structure-based approaches integrate spatial and conformational data into high-resolution interaction models. The hybrid use of these three approaches could significantly increase the success rate of

Indexed as

binding affinity predictiondeep learning (DL)drug–target binding affinityG protein–coupled receptors (GPCRs)machine learning (ML)

Identifiers

PMID41601476
PMCPMC12832930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.